0001817835-20-000001.txt : 20200713 0001817835-20-000001.hdr.sgml : 20200713 20200713145441 ACCESSION NUMBER: 0001817835-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 EFFECTIVENESS DATE: 20200713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nerio Therapeutics, Inc. CENTRAL INDEX KEY: 0001817835 IRS NUMBER: 842075367 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370830 FILM NUMBER: 201025091 BUSINESS ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001817835 Nerio Therapeutics, Inc. 11099 TORREY PINES PARK ROAD, SUITE 290 LA JOLLA CA CALIFORNIA 92037 858-750-4700 DELAWARE None None Corporation true 2019 Sanford J. Madigan, Ph.D. 11099 North Torrey Pines Park Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Jay Lichter, Ph.D. 11099 North Torrey Pines Park Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Tighe Reardon 11099 North Torrey Pines Park Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Stefan Heller 11099 North Torrey Pines Park Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2020-06-30 false true false 0 5752853 3002850 2750003 Total Offering Amount and Total Amount Sold include amounts paid pursuant to conversion of indebtedness. false 5 0 0 0 false Nerio Therapeutics, Inc. /s/ Sanford J. Madigan Sanford J. Madigan Chief Executive Officer 2020-07-11